Lixisenatide for type 2 diabetes mellitus

Author： Christensen Mikkel Knop Filip K Vilsbøøll Tina Holst Jens J

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.4, 2011-04, pp. : 549-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus

By Forst Thomas Pfützner Andreas

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2281-2296

Informa Healthcare

Access to resources Recommend Favorite

Linagliptin: In Type 2 Diabetes Mellitus

By Scott Lesley J.

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 611-624

Adis International

Access to resources Recommend Favorite

The prevention of type 2 diabetes mellitus

By Davies Melanie J.

Clinical Medicine, Vol. 3, Iss. 5, 2003-09 ,pp. : 470-474

Royal College Of Physicians

Access to resources Recommend Favorite

Vitamins and Type 2 Diabetes Mellitus

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 1, 2015-03 ,pp. : 54-63

Bentham Science Publishers

Access to resources Recommend Favorite

The Pharmaceutical care of patients with type 2 diabetes mellitus

By Borges Anna

Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. : 730-736

Springer Publishing Company

Access to resources Recommend Favorite